PTPRC and lymphopenia: Upon quantification of major immune populations, we confirmed COVID‐19‐associated lymphopenia (< 20% CD45+ leucocytes) in both ND and T2D patients (Fig 1A and Appendix Fig S1B)(Melzer et al, 2015).